In the present study, we evaluated the effects of prolonged treatment of T2D mice with daily injections of adropin for four weeks on glucose tolerance, insulin sensitivity, body weight, lipid metabolism, circulating adipokines, insulin and glucagon as well as pancreatic islet morphology and the liver metabolic parameters. This evidence concerns the gene GCG and type 2 diabetes mellitus.